Increased prevalence of gastroesophageal reflux symptoms in patients with COPD

Study objectives: To determine the prevalence of gastroesophageal reflux (GER) symptoms in patients with COPD and the association of GER symptoms with the severity of airways obstruction as assessed by pulmonary function tests (PETs), Design: Prospective questionnaire-based, cross-sectional analytic survey. Setting: Outpatient pulmonary and general medicine clinics at a Veterans Administration hospital. Patients: Patients with mild-to-severe COPD (n = 100) were defined based on American Thoracic Society criteria, The control group (n = 51) consisted of patients in the general medicine clinic without respiratory complaints or prior diagnosis of asthma or COPD, Intervention: Both groups completed a modified version of the Mayo Clinic GER questionnaire. Results: Compared to control subjects, a greater proportion of COPD patients had significant GER symptoms defined as heartburn and/or regurgitation once or more per week (19% vs 0%, respectively; p < 0.001), chronic cough (32% vs 16%; p = 0.03), and dysphagia (17% vs 4%; p = 0.02). Among patients with COPD and significant GER symptoms, 26% reported respiratory symptoms associated with reflux events, whereas control subjects denied an association. Significant GER symptoms were more prevalent in COPD patients with FEV1 <less than or equal to> 50%, as compared with patients with FEV1 > 50% of predicted (23% vs 9%, respectively; p = 0.08). In contrast, PET results were similar among COPD patients with and without GER symptoms. An increased number of patients with COPD utilized antireflux medications, compared to control subjects (50% vs 27%, respectively; p = 0.008). Conclusions: The questionnaire demonstrated a higher prevalence of weekly GER symptoms in patients with COPD, as compared to control subjects. There was a trend toward higher prevalence of GER symptoms in patients with severe COPD; however, this difference did not reach statistical significance. We speculate that: although GER may not worsen pulmonary function, greater expiratory airflow limitation may worsen GER symptoms in patients with COPD.